Covera-HS, a new timed-release verapamil designed for BEDTIME dosing

Searle will soon launch Covera-HS, a new timed-release verapamil designed for BEDTIME dosing.

It's approved for either hypertension or angina.

The idea is to provide peak effects in the MORNING when blood pressure and heart rate tend to be highest...and patients are most vulnerable to chest pain or a heart attack.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote